PGNewsroom



New Comprehensive Inherited Retinal Dystrophies Panel

Published on

As the leading provider in genetic testing for inherited eye disorders, we are excited to introduce our new 304 gene comprehensive inherited retinal dystrophies (IRD) panel for the same price as our previous IRD panel (107 genes). Because of genetic heterogeneity and phenotypic overlap, identifying the genetic cause of IRD is often challenging. This panel has been carefully curated to maximize clinical sensitivity and to achieve molecular diagnosis for IRDs.

PreventionGenetics Releases Genetic Tests for Infertility

Published on

Marshfield, WI – PreventionGenetics has launched new genetic tests for both female and male infertility. Infertility affects 10-20% of couples worldwide and is generally attributed to males and females equally. It is estimated that genetic abnormalities including both chromosomal and single-gene alterations can account for up to 30% of cases of infertility (Hotaling 2014).

PreventionGenetics Releases New Panels for Infertility and
Disorders of Sex Development

Published on

Infertility is a disorder of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse. It affects 10-20% of couples worldwide and is generally attributed to males and females equally.  Infertility evaluations can be an emotional and financial burden for couples.   An infertility evaluation can involve extensive tests including imaging, blood work, semen analysis, biopsies, laparoscopies and more, costing thousands of dollars without a promise to result in a successful pregnancy.  It is estimated that genetic abnormalities including both chromosomal and single-gene alterations can account for up to 30% of cases of infertility (Hotaling 2014). At PreventionGenetics we are committed to helping couples find these genetic answers, offering a Comprehensive Panel, as well as sub panels for Female Infertility, Male Infertility and Disorders of Sex Development.

PreventionGenetics Receives New York License for Genetic Tests  

Published on

PreventionGenetics, LLC has received a New York State Department of Health license.  The company has long held Clinical Laboratory Improvement Amendments (CLIA) and International Organization for Standards (ISO) 15189:2012 accreditations, allowing clinical genetic testing on human specimens in the United States and internationally. A few states, including New York, require additional licensure.  

Our Neuromuscular Test Menu Just Got Stronger

Published on

At PreventionGenetics, we’re constantly striving to provide the best genetic tests possible.We have updated several of our panels for specific neuromuscular disorders (NMDs) including Congenital Myopathy, Limb-Girdle Muscular Dystrophy, and  Myofibrillar Myopathy.  A 124 gene Comprehensive Neuromuscular Panel as well as a 83 gene Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Sequencing Panel are now available.